Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Diluted EPS of $0.09 per share (loss) for fiscal year 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.09 | +80.4% |
| 2024 | -$0.46 | +29.2% |
| 2023 | -$0.65 | -3.2% |
| 2022 | -$0.63 | +32.3% |
| 2021 | -$0.93 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.03 | -150.0% | +0.0% |
| June 30, 2025 | -$0.03 | +70.0% | +57.1% |
| March 31, 2025 | -$0.07 | +36.4% | -216.7% |
| December 31, 2024 | $0.06 | +142.9% | +160.0% |
| June 30, 2024 | -$0.10 | +50.0% | +9.1% |
| March 31, 2024 | -$0.11 | +47.6% | +21.4% |
| December 31, 2023 | -$0.14 | -27.3% | +30.0% |
| June 30, 2023 | -$0.20 | -17.6% | +4.8% |
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +80.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, NEUROONE MEDICAL TECHNOLOGIES Corp’s diluted eps has grown by 90.3% (from $0.93 per share (loss) to $0.09 per share (loss)).
- The most recent figure is from NEUROONE MEDICAL TECHNOLOGIES Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: